Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

Patients with kidney failure who are receiving maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SAR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2021-10, Vol.78 (4), p.571-581
Hauptverfasser:	Broseta, José Jesús, Rodríguez-Espinosa, Diana, Rodríguez, Néstor, Mosquera, María del Mar, Marcos, María Ángeles, Egri, Natalia, Pascal, Mariona, Soruco, Erica, Bedini, José Luis, Bayés, Beatriu, Maduell, Francisco
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Adult Aged Aged, 80 and over Antibody response BNT162 Vaccine cellular response Cohort Studies COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage end-stage renal disease (ESRD) Female hemodialysis Humans humoral response Immunity, Cellular - immunology Immunity, Humoral - immunology immunogenicity immunosuppression Male Middle Aged mRNA vaccines Original Investigation Prospective Studies Renal Dialysis SARS-CoV-2 seroconversion T-Lymphocytes - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!